Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;22(5):e202100335.
doi: 10.1002/tcr.202100335. Epub 2022 Mar 7.

Fluorinated Nucleosides: Synthesis, Modulation in Conformation and Therapeutic Application

Affiliations
Review

Fluorinated Nucleosides: Synthesis, Modulation in Conformation and Therapeutic Application

Shantanu Pal et al. Chem Rec. 2022 May.

Abstract

Over the last twenty years, fluorination on nucleoside has established itself as the most promising tool to use to get biologically active compounds that could sustain the clinical trial by affecting the pharmacodynamics and pharmacokinetic properties. Due to fluorine's inherent unique properties and its judicious introduction into the molecule, makes the corresponding nucleoside metabolically very stable, lipophilic, and opens a new site of intermolecular binding. Fluorination on various nucleosides has been extensively studied as a result, a series of fluorinated nucleosides come up for different therapeutic uses which are either approved by the FDA or under the advanced stage of the clinical trial. Here in this review, we are summarizing the latest development in the chemistry of fluorination on nucleoside that led to varieties of new analogs like carbocyclic, acyclic, and conformationally biased nucleoside and their biological properties, the influence of fluorine on conformation, oligonucleotide stability, and their use in therapeutics.

Keywords: Anticancer; Antiviral; Conformational Modulation; Drug design; Fluorination; Nucleobases; Nucleosides.

PubMed Disclaimer

References

    1. None
    1. E. De Clercq, Biochem. Pharmacol. 2013, 86, 711-725;
    1. X. Lin, C. Liang, L. Zou, Y. Yin, J. Wang, D. Chen, W. Lan, Eur. J. Med. Chem. 2021, 214, 113233.
    1. V. E. Kataev, B. F. Garifullin, Chem. Heterocycl. Compd. 2021, 57, 326-341.
    1. None

LinkOut - more resources